Detalhe da pesquisa
1.
Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment.
Strahlenther Onkol
; 197(12): 1051-1062, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34673991
2.
The importance of jointly analyzing treatment administration and toxicity associated with targeted therapies: a case study of regorafenib in soft tissue sarcoma patients.
Ann Oncol
; 29(7): 1588-1593, 2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29722789
3.
Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas.
Ann Oncol
; 29(8): 1828-1835, 2018 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29860427
4.
Prospective Assessment of First-Year Quality of Life After Pelvic Exenteration for Gynecologic Malignancy: A French Multicentric Study.
Ann Surg Oncol
; 25(2): 535-541, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29159738
5.
Statistical controversies in clinical research: should schedules of tumor size assessments be changed?
Ann Oncol
; 27(11): 1981-1987, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27502711
6.
How to report toxicity associated with targeted therapies?
Ann Oncol
; 27(8): 1633-8, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27217543
7.
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.
Ann Oncol
; 27(2): 281-6, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26598547
8.
Prediction of long-term cumulative incidences based on short-term parametric model for competing risks: application in early breast cancer.
Breast Cancer Res Treat
; 156(3): 577-585, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-27075918
9.
Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer.
Ann Surg Oncol
; 23(8): 2515-21, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27008588
10.
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project.
Ann Oncol
; 26(12): 2392-8, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26371288
11.
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 865-872, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25070543
12.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials).
Ann Oncol
; 26(5): 873-879, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25725046
13.
The frontal branch of the facial nerve: can we define a safety zone?
Surg Radiol Anat
; 37(5): 499-506, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25342224
14.
What risk of prostate cancer led urologist to recommend prostate biopsies?
Prog Urol
; 25(16): 1125-31, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26431746
15.
Éditorial.
Rev Epidemiol Sante Publique
; 67 Suppl 3: S119, 2019 05.
Artigo
Francês
| MEDLINE | ID: mdl-30955996
16.
Dermatofibrosarcoma protuberans: margins reduction using slow-Mohs micrographic surgery. Experience with 35 patients.
Ann Chir Plast Esthet
; 59(4): 219-25, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24411817
17.
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.
ESMO Open
; 9(5): 103447, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38703431
18.
Clinical characteristic and survival outcomes of patients with advanced NSCLC according to KRAS mutational status in the French real-life ESME cohort.
ESMO Open
; 9(6): 103473, 2024 Jun 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38833966
19.
Accuracy of intraoperative pathological examination of SLN in cervical cancer.
Gynecol Oncol
; 130(3): 525-9, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23500089
20.
Reduced risk of secondary primary extra pulmonary cancer in advanced/metastatic lung cancer patients treated with immune checkpoint inhibitors.
Lung Cancer
; 182: 107280, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37339550